Filing Details
- Accession Number:
- 0001477932-20-007402
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-21 08:28:16
- Reporting Period:
- 2020-12-18
- Accepted Time:
- 2020-12-21 08:28:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1643301 | Cure Pharmaceutical Holding Corp. | CURR | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1412747 | Steven Robert Davidson | 1620 Beacon Place Oxnard CA 93033 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-12-18 | 2,300 | $1.42 | 537,769 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-12-18 | 2,415 | $1.45 | 540,184 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-12-18 | 2,172 | $1.44 | 542,356 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- Open market purchases reported on this line occurred at a weighted average price of $1.42 (range $1.415 to $1.430). Mr. Davidson undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price.
- Open market purchases reported on this line occurred at a weighted average price of $1.44 (range $1.425 to $1.460). Mr. Davidson undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price.